Biofrontera Inc (BFRI)

NASDAQ

$0.99

Biofrontera Inc., a biopharmaceutical company, develops and supplies dermatological products for the treatment of skin conditions in the United States. The company is headquartered in Woburn, Massachusetts.

Website: https://www.biofrontera-us.com

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

68 analysts

Buy

Target: $5.88 (+496.65%)

Market Cap

$10M

Free Cash Flow Yield

-91.51%

Beta (5Y)

0.94

Price Chart

Adjust inflation

Log

Valuation

Market Cap$10M

Forward P/E13.64

P/S0.26

P/B1.81

Profitability

Total Revenue (TTM)$43M

Gross Profit (TTM)$33M

EBITDA-$11M

Profit Margin-47.1%

Operating Margin-42.8%

EPS-$1.01

Financial Health

Free Cash Flow Yield-91.51%

Growth & Risk

Beta (5Y)0.94

Sharpe Ratio1.10